{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:24:50Z","timestamp":1792686290500,"version":"4.5.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chest"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1378\/chest.15-0959","type":"journal-article","created":{"date-parts":[[2015,8,13]],"date-time":"2015-08-13T12:31:21Z","timestamp":1439469081000},"page":"74-83","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":78,"title":["Practice Patterns and Outcomes of Treatments for Atrial Fibrillation During Sepsis"],"prefix":"10.1016","volume":"149","author":[{"given":"Allan J.","family":"Walkey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen R.","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"Winter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emelia J.","family":"Benjamin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1378\/chest.15-0959_bib1","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1513\/AnnalsATS.201411-498BC","article-title":"Trends in sepsis and infection sources in the United States. A population-based study","volume":"12","author":"Walkey","year":"2015","journal-title":"Ann Am Thorac Soc"},{"issue":"1","key":"10.1378\/chest.15-0959_bib2","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1001\/jama.2014.5804","article-title":"Hospital deaths in patients with sepsis from 2 independent cohorts","volume":"312","author":"Liu","year":"2014","journal-title":"JAMA"},{"issue":"6","key":"10.1378\/chest.15-0959_bib3","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.ahj.2013.03.020","article-title":"Atrial fibrillation among Medicare beneficiaries hospitalized with sepsis: incidence and risk factors","volume":"165","author":"Walkey","year":"2013","journal-title":"Am Heart J"},{"issue":"22","key":"10.1378\/chest.15-0959_bib4","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1016\/j.jacc.2014.09.034","article-title":"New-onset atrial fibrillation during hospitalization","volume":"64","author":"Walkey","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"1","key":"10.1378\/chest.15-0959_bib5","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1164\/rccm.200701-031OC","article-title":"Incidence and prognosis of sustained arrhythmias in critically ill patients","volume":"178","author":"Annane","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"issue":"20","key":"10.1378\/chest.15-0959_bib6","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1001\/jama.2011.1615","article-title":"Incident stroke and mortality associated with new-onset atrial fibrillation in patients hospitalized with severe sepsis","volume":"306","author":"Walkey","year":"2011","journal-title":"JAMA"},{"issue":"3","key":"10.1378\/chest.15-0959_bib7","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1177\/0885066608315838","article-title":"Paroxysmal atrial fibrillation in critically ill patients with sepsis","volume":"23","author":"Salman","year":"2008","journal-title":"J\u00a0Intensive Care Med"},{"issue":"4","key":"10.1378\/chest.15-0959_bib8","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.jcrc.2007.09.005","article-title":"Clinical characteristics and outcomes of septic patients with new-onset atrial fibrillation","volume":"23","author":"Christian","year":"2008","journal-title":"J\u00a0Crit Care"},{"issue":"4","key":"10.1378\/chest.15-0959_bib9","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1213\/01.ane.0000255759.41131.05","article-title":"Supraventricular arrhythmias in intensive care unit patients: short and long-term consequences","volume":"104","author":"Goodman","year":"2007","journal-title":"Anesth Analg"},{"issue":"5","key":"10.1378\/chest.15-0959_bib10","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1378\/chest.14-0003","article-title":"Long-term outcomes following development of new-onset atrial fibrillation during sepsis","volume":"146","author":"Walkey","year":"2014","journal-title":"Chest"},{"issue":"21","key":"10.1378\/chest.15-0959_bib11","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jacc.2014.03.022","article-title":"2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society","volume":"64","author":"January","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"2","key":"10.1378\/chest.15-0959_bib12","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/01.CCM.0000048627.39686.79","article-title":"Effectiveness of direct-current cardioversion for treatment of supraventricular tachyarrhythmias, in particular atrial fibrillation, in surgical intensive care patients","volume":"31","author":"Mayr","year":"2003","journal-title":"Crit Care Med"},{"issue":"6","key":"10.1378\/chest.15-0959_bib13","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1097\/00003246-200106000-00011","article-title":"Amiodarone versus diltiazem for rate control in critically ill patients with atrial tachyarrhythmias","volume":"29","author":"Delle Karth","year":"2001","journal-title":"Crit Care Med"},{"issue":"4","key":"10.1378\/chest.15-0959_bib14","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1136\/hrt.64.4.256","article-title":"Placebo controlled trial of xamoterol versus digoxin in chronic atrial fibrillation","volume":"64","author":"Ang","year":"1990","journal-title":"Br Heart J"},{"issue":"24","key":"10.1378\/chest.15-0959_bib15","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1161\/01.CIR.0000132482.95686.87","article-title":"Digoxin in the management of cardiovascular disorders","volume":"109","author":"Gheorghiade","year":"2004","journal-title":"Circulation"},{"issue":"4","key":"10.1378\/chest.15-0959_bib16","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1093\/oxfordjournals.eurheartj.a060945","article-title":"Acute treatment of recent-onset atrial fibrillation and flutter with a tailored dosing regimen of intravenous amiodarone. A randomized, digoxin-controlled study","volume":"16","author":"Hou","year":"1995","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1378\/chest.15-0959_bib17","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1097\/CCM.0b013e3181709e43","article-title":"Treatment of new-onset atrial fibrillation in noncardiac intensive care unit patients: a systematic review of randomized controlled trials","volume":"36","author":"Kanji","year":"2008","journal-title":"Crit Care Med"},{"issue":"6","key":"10.1378\/chest.15-0959_bib18","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.1097\/MLR.0b013e318268ac86","article-title":"Identifying patients with severe sepsis using administrative claims: patient-level validation of the angus implementation of the international consensus conference definition of severe sepsis","volume":"56","author":"Iwashyna","year":"2014","journal-title":"Med Care"},{"issue":"suppl 1","key":"10.1378\/chest.15-0959_bib19","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/pds.2317","article-title":"A\u00a0systematic review of validated methods for identifying atrial fibrillation\u00a0using administrative data","volume":"21","author":"Jensen","year":"2012","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"1","key":"10.1378\/chest.15-0959_bib20","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/biomet\/70.1.41","article-title":"The central role of the propensity score in observational studies for causal effects","volume":"70","author":"Rosenbaum","year":"1983","journal-title":"Biometrika"},{"issue":"8","key":"10.1378\/chest.15-0959_bib21","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1093\/aje\/kwf095","article-title":"Modeling treatment effects on binary outcomes with\u00a0grouped-treatment variables and individual covariates","volume":"156","author":"Johnston","year":"2002","journal-title":"Am J Epidemiol"},{"issue":"4","key":"10.1378\/chest.15-0959_bib22","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1136\/jech.2004.029454","article-title":"A\u00a0brief conceptual tutorial of multilevel analysis in social epidemiology: using measures of clustering in multilevel logistic regression to investigate contextual phenomena","volume":"60","author":"Merlo","year":"2006","journal-title":"J\u00a0Epidemiol Community Health"},{"issue":"21","key":"10.1378\/chest.15-0959_bib23","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.1002\/sim.1264","article-title":"Multilevel modelling of medical data","volume":"21","author":"Goldstein","year":"2002","journal-title":"Stat Med"},{"issue":"5","key":"10.1378\/chest.15-0959_bib24","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1111\/j.1475-6773.2012.01402.x","article-title":"Hospital-level variation in the use of intensive care","volume":"47","author":"Seymour","year":"2012","journal-title":"Health Serv Res"},{"issue":"7","key":"10.1378\/chest.15-0959_bib25","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/j.jacc.2003.11.032","article-title":"The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study: approaches to control rate in atrial fibrillation","volume":"43","author":"Olshansky","year":"2004","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"1","key":"10.1378\/chest.15-0959_bib26","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1067\/mhj.2000.106917","article-title":"Esmolol versus diltiazem in the treatment of postoperative atrial fibrillation\/atrial flutter after open heart surgery","volume":"140","author":"Mooss","year":"2000","journal-title":"Am Heart J"},{"issue":"5","key":"10.1378\/chest.15-0959_bib27","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1097\/00000542-199811000-00004","article-title":"Beta-adrenergic blockade accelerates conversion of postoperative supraventricular tachyarrhythmias","volume":"89","author":"Balser","year":"1998","journal-title":"Anesthesiology"},{"issue":"13","key":"10.1378\/chest.15-0959_bib28","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/0002-9149(89)90141-0","article-title":"Esmolol versus verapamil in the acute treatment of atrial fibrillation or atrial flutter","volume":"63","author":"Platia","year":"1989","journal-title":"Am J Cardiol"},{"issue":"2","key":"10.1378\/chest.15-0959_bib29","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1177\/107424840200700204","article-title":"Effects of diltiazem and esmolol on cycle length and spontaneous conversion of atrial fibrillation","volume":"7","author":"Sticherling","year":"2002","journal-title":"J\u00a0Cardiovasc Pharmacol Ther"},{"issue":"16","key":"10.1378\/chest.15-0959_bib30","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1001\/jama.2013.278477","article-title":"Effect of heart rate control with esmolol on hemodynamic and clinical outcomes in patients with septic shock: a randomized clinical trial","volume":"310","author":"Morelli","year":"2013","journal-title":"JAMA"},{"issue":"9","key":"10.1378\/chest.15-0959_bib31","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1097\/CCM.0b013e31828a678d","article-title":"Microvascular effects of heart rate control with esmolol in patients with septic shock: a pilot study","volume":"41","author":"Morelli","year":"2013","journal-title":"Crit Care Med"},{"issue":"2","key":"10.1378\/chest.15-0959_bib32","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/TA.0000000000000113","article-title":"Inhibition of sepsis-induced inflammatory response by \u03b21-adrenergic antagonists","volume":"76","author":"Ibrahim-Zada","year":"2014","journal-title":"J\u00a0Trauma Acute Care Surg"},{"issue":"11","key":"10.1378\/chest.15-0959_bib33","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1007\/s00134-011-2326-x","article-title":"Beta-1 blocker improves survival of septic rats through preservation of gut barrier function","volume":"37","author":"Mori","year":"2011","journal-title":"Intensive Care Med"},{"issue":"7","key":"10.1378\/chest.15-0959_bib34","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.amjcard.2015.01.013","article-title":"Meta-analysis of digoxin use and risk of mortality in patients with atrial fibrillation","volume":"115","author":"Ouyang","year":"2015","journal-title":"Am J Cardiol"},{"key":"10.1378\/chest.15-0959_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijcard.2014.11.112","article-title":"Digoxin treatment is associated with increased total and cardiovascular mortality in anticoagulated patients with atrial fibrillation","volume":"180","author":"Pastori","year":"2015","journal-title":"Int J Cardiol"},{"issue":"7","key":"10.1378\/chest.15-0959_bib36","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.jacc.2014.03.060","article-title":"Increased mortality associated with digoxin in contemporary patients with atrial fibrillation: findings from the TREAT-AF study","volume":"64","author":"Turakhia","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"20","key":"10.1378\/chest.15-0959_bib37","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1093\/eurheartj\/ehs348","article-title":"Increased mortality among patients taking digoxin\u2013analysis from the AFFIRM study","volume":"34","author":"Whitbeck","year":"2013","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1378\/chest.15-0959_bib38","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ahj.2014.03.024","article-title":"Trends in the pharmacologic management of atrial fibrillation: data from the Veterans Affairs health system","volume":"168","author":"Vaughan-Sarrazin","year":"2014","journal-title":"Am Heart J"},{"issue":"11","key":"10.1378\/chest.15-0959_bib39","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1097\/00003246-199511000-00005","article-title":"Parenteral magnesium sulfate versus amiodarone in the therapy of atrial tachyarrhythmias: a prospective, randomized study","volume":"23","author":"Moran","year":"1995","journal-title":"Crit Care Med"},{"issue":"11","key":"10.1378\/chest.15-0959_bib40","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1097\/CCM.0b013e31822572e3","article-title":"Development and validation of a model that uses enhanced administrative data to predict mortality in patients with sepsis","volume":"39","author":"Lagu","year":"2011","journal-title":"Crit Care Med"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369215001361?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369215001361?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,20]],"date-time":"2018-09-20T03:28:20Z","timestamp":1537414100000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369215001361"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["S0012369215001361"],"URL":"https:\/\/doi.org\/10.1378\/chest.15-0959","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Practice Patterns and Outcomes of Treatments for Atrial Fibrillation During Sepsis","name":"articletitle","label":"Article Title"},{"value":"Chest","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1378\/chest.15-0959","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}